Related Experiment Video

Updated: Jul 20, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.6K

Editorial: Unravelling real-world impact of second-line therapies in primary biliary cholangitis-Time to change our

C M Fernández-Rodríguez1,2, M L Gutierrez1, A Olveira3

  • 1Hospital Universitario Fundación Alcorcón, Madrid, Spain.

Alimentary Pharmacology & Therapeutics
|May 22, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.4K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

410

Related Experiment Videos

Last Updated: Jul 20, 2026

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.6K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

2.4K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

410

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Articles linked to this work by shared authors, journal, and citation graph.

Cumulative Metformin Use and Hepatocellular Carcinoma Risk After HCV SVR: A Multicentre Cohort Study.

Liver international : official journal of the International Association for the Study of the Liver·2026

Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.

Dermatology and therapy·2026

Reconnecting hepatitis C patients lost to follow-up ‒ A targeted strategy.

Revista espanola de enfermedades digestivas·2025

Role of the gastroenterologist in the comprehensive management of people living with obesity. SEPD Position Paper.

Revista espanola de enfermedades digestivas·2025

Prospective validation of the EASL-EASD algorithm for risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes.

Revista espanola de enfermedades digestivas·2025

The liver as a thermometer of cardiometabolic health: time to prioritize MASLD in global health policy.

Revista espanola de enfermedades digestivas·2025

The TOP-GERD Trial: Comparative Efficacy of Tegoprazan Versus Pantoprazole in the Treatment of Erosive Oesophagitis in a Non-Asian Population.

Alimentary pharmacology & therapeutics·2026

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

Alimentary pharmacology & therapeutics·2026

Systematic Review: Inclusion of Patients With Difficult-to-Treat Inflammatory Bowel Disease in Randomized Controlled Trials of Advanced Therapies.

Alimentary pharmacology & therapeutics·2026

Clinical trial: The Effect on Intragastric pH and Pharmacokinetics of the PCAB Linaprazan Glurate in Healthy Subjects After Repeat-Dose Administration for up to 14 Days.

Alimentary pharmacology & therapeutics·2026

Accelerated Biological Aging in Cholestatic Liver Disease: Telomere Attrition and Association With Disease Severity.

Alimentary pharmacology & therapeutics·2026

Review Article: Cancer Surveillance for Early Detection of Liver Cancer in Patients with HBV Infection.

Alimentary pharmacology & therapeutics·2026

Longitudinal Surgical Modeling of Early Glioblastoma Recurrence Reveals Emergence of Margin-Associated Neural Programs.

Cancer research·2026

Enhancement of oncolytic flavi- and alphavirus replication in resistant human pancreatic adenocarcinoma cell lines using ruxolitinib.

Voprosy virusologii·2026

[Therapeutic success of sacituzumab govitecan in a patient with a primary diagnosis of triple-cancer: locally advanced triple-negative breast cancer, colon cancer and lung cancer.]

Recenti progressi in medicina·2026

[Systemic therapy for advanced triple-negative breast cancer in older women: strategy optimization and effectiveness of sacituzumab govitecan.]

Recenti progressi in medicina·2026

SurgiCorr: A Physics-Based Computational Framework for Patient-Specific Surgical Corridor Planning in Brain Tumor Surgery.

Operative neurosurgery (Hagerstown, Md.)·2026

Size and sequence variation of the Lid of the Cas12a nuclease domain results in a nickase phenotype.

Nucleic acids research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us